Assignee
GALECTIN THERAPEUTICS INC
US·14 granted patents·4 pending applications·53 citations·filing 2011–2025
Top patents by PatentIndex Score
18 records- 0195US8962824B2Composition of novel carbohydrate drug for treatment of human diseasesGALECTIN THERAPEUTICS INC·Filed 2014·Granted Feb 24, 2015·11 cites·30 claims
- 0291US9339515B2Method for treatment of pulmonary fibrosisGALECTIN THERAPEUTICS INC·Filed 2014·Granted May 17, 2016·8 cites·10 claims
- 0388US9974802B2Composition of novel carbohydrate drug for treatment of human diseasesGALECTIN THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·4 cites·13 claims
- 0488US8828971B2Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disordersGALECTIN THERAPEUTICS INC·Filed 2013·Granted Sep 9, 2014·12 cites·18 claims
- 0587US2026053840A1Composition of novel carbohydrate drug for treatment of human diseasesGALECTIN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0686US10420793B2Composition of novel carbohydrate drug for treatment of human diseasesGALECTIN THERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·1 cites·17 claims
- 0786US9649327B2Composition of novel carbohydrate drug for treatment of human diseasesGALECTIN THERAPEUTICS INC·Filed 2014·Granted May 16, 2017·5 cites·19 claims
- 0885US9968631B2Method for treatment of pulmonary fibrosisGALECTIN THERAPEUTICS INC·Filed 2016·Granted May 15, 2018·2 cites·11 claims
- 0984US9200090B2Galactose-pronged polysaccharides in a formulation for antifibrotic therapiesGALECTIN THERAPEUTICS INC·Filed 2012·Granted Dec 1, 2015·4 cites·9 claims
- 1082US2023000898A1Composition of novel carbohydrate drug for treatment of human diseasesGALECTIN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1179US10799525B2Composition of novel carbohydrate drug for treatment of human diseasesGALECTIN THERAPEUTICS INC·Filed 2019·Granted Oct 13, 2020·0 cites·18 claims
- 1279US10398778B2Method for enhancing specific immunotherapies in cancer treatmentGALECTIN THERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·3 cites·19 claims
- 1376US11413303B2Methods for treatment of arthritisGALECTIN THERAPEUTICS INC·Filed 2020·Granted Aug 16, 2022·0 cites·20 claims
- 1474US8367638B2Galactose-pronged polysaccharides in a formulation for antifibrotic therapiesGALECTIN THERAPEUTICS INC·Filed 2011·Granted Feb 5, 2013·1 cites·9 claims
- 1573US9763974B2Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthaseGALECTIN THERAPEUTICS INC·Filed 2013·Granted Sep 19, 2017·2 cites·14 claims
- 1673US2021008097A1Compositions Comprising Galactose-Pronged PolysaccharidesGALECTIN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1766US10744154B2Galactose-pronged polysaccharides in a formulation for antifibrotic therapiesGALECTIN THERAPEUTICS INC·Filed 2017·Granted Aug 18, 2020·0 cites·17 claims
- 1859US2016058785A1Galactose-pronged polysaccharides in a formulation for antifibrotic therapiesGALECTIN THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GALECTIN THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →